Fos-related antigen immunoreactivity after acute and chronic angiotensin II-induced hypertension in the rabbit brain.
Several brain regions are proposed as contributing to chronic sympatho-excitatory effects of elevated circulating angiotensin II. However, earlier c-Fos studies have been limited to acute angiotensin II exposure. This study aims to determine brain regions responding with chronic elevated angiotensin II. Rabbits were administered angiotensin II (50 ng/kg per minute) or saline for 3 hours, 3 days, or 14 days. Basal mean arterial pressure was 71+/-2 mm Hg and increased 23+/-2 mm Hg, 32+/-4 mm Hg, and 22+/-2 mm Hg for 3 hours, 3 days, and 14 days, respectively, with angiotensin II infusion. Neuronal activation was detected using Fos-related antigens, which recognizes all of the known members of the Fos family. Neurons located in the amygdala and area postrema were activated transiently after acute infusion of angiotensin II but were not responsive by days 3 or 14. Neurons located in the nucleus of the solitary tract, caudal ventrolateral medulla, and lateral parabrachial nucleus were activated for <or=3 days after infusion of angiotensin II but were not responsive by day 14, which is consistent with their role in response to baroreceptor pathways that reset with sustained hypertension. The vascular organ of the lamina terminalis and subfornical organ showed sustained but diminishing activation over the 14-day period. However, the downstream hypothalamic nuclei that receive inputs from these nuclei, the paraventricular, supraoptic, and arcuate nuclei, showed marked sustained activation. These findings suggest that there is desensitization of circumventricular organs but sensitization of neurons in hypothalamic regions to long-term angiotensin II infusion.
Davern
Pamela J
PJ
Neuropharmacology Laboratory, Baker Heart Research Institute, Melbourne, Victoria, Australia. pamela.davern@baker.edu.au
Head
Geoffrey A
GA
D000804:Angiotensin II / Q000008:administration & dosage*; D000818:Animals; D001794:Blood Pressure; D001921:Brain / Q000378:metabolism* / Q000503:physiopathology; D004334:Drug Administration Schedule; D006973:Hypertension / Q000139:chemically induced* / Q000276:immunology* / Q000503:physiopathology; D007150:Immunohistochemistry; D008297:Male; D016760:Proto-Oncogene Proteins c-fos / Q000378:metabolism*; D011817:Rabbits; D013997:Time Factors; D014018:Tissue Distribution; D014662:Vasoconstrictor Agents / Q000008:administration & dosage*
D016760:Proto-Oncogene Proteins c-fos; D014662:Vasoconstrictor Agents; D000804:Angiotensin II